subject: Aarkstore Enterprise---ats Medical, Inc. (atsi) - Financial And Strategic Analysis Review [print this page] ATS Medical, IncATS Medical, Inc. (ATS) is engaged in the development, manufacturing and marketing of products and services used for cardiac surgeries. The company offers medical devices for the treatment of structural heart disease focusing on heart valve therapy and devices for the surgical treatment of cardiac arrhythmia. Heart valve therapy devices are sub categorized into mechanical and tissue heart valves and heart valve repair products. Additionally, the surgical arrhythmia therapy products consist of cryotherapy products for the ablation of cardiac arrhythmias. ATS operates in the US, Germany, Austria, France and China. ATSis headquartered in Minnesota, the US
ATS Medical, Inc. Key Recent Developments
Mar 22, 2010: ATS Medical Gains Canadian Approval For Commercialization Of Simulus Annuloplasty Product Line
Mar 22, 2010: ATS Medical Gets Approval To Commercialise Simulus Annuloplasty Products
Mar 01, 2010: ATS Medical Reports Net Sales Of $75.7 Million In 2009
Feb 01, 2010: ATS Medical Appoints Xavier Bertrand As New Vice President And General Manager For EMEA
Jan 25, 2010: ATS Medical Reports First Implants Of ATS 3f Enable Aortic Bioprosthesis
This comprehensive SWOT analysis of ATS Medical, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
